Neuroscience is the scientific study of the nervous system, its functions and disorders. It is a multidisciplinary science that combines physiology, anatomy, molecular biology, developmental biology, cytology, psychology, physics, computer science, chemistry, medicine, statistics, and mathematical modeling to understand the fundamental and emergent properties of neurons, glia and neural circuits. The understanding of the biological basis of learning, memory, behavior, perception, and consciousness has been described by Eric Kandel as the "epic challenge" of the biological sciences.
Eric Richard Kandel is an Austrian-born American medical doctor who specialized in psychiatry, a neuroscientist and a professor of biochemistry and biophysics at the College of Physicians and Surgeons at Columbia University. He was a recipient of the 2000 Nobel Prize in Physiology or Medicine for his research on the physiological basis of memory storage in neurons. He shared the prize with Arvid Carlsson and Paul Greengard.
The University of California, Los Angeles School of Medicine also known as the David Geffen School of Medicine at UCLA (DGSOM)—is an accredited medical school located in Los Angeles, California, United States. The school was renamed in 2001 in honor of media mogul David Geffen who donated $200 million in unrestricted funds. Founded in 1951, it is the second medical school in the University of California system, after the UCSF School of Medicine.
Gerald D. Fischbach is an American neuroscientist. He received his M.D. from the Weill Cornell Medical College of Cornell University in 1965 before beginning his research career at the National Institutes of Health in 1966, where his research focused on the mechanisms of neuromuscular junctions. After his tenure at the National Institutes of Health, Fischbach was a professor at Harvard University Medical School from 1972 to 1981 and from 1990 to 1998 and the Washington University School of Medicine from 1981 to 1990. In 1998, he was named the director of the National Institute of Neurological Disorders and Stroke before becoming the Vice President and Dean of the Health and Biomedical Sciences, the Dean of the Faculty of Medicine, and the Dean of the Faculty of Health Sciences at Columbia University from 2001 to 2006. Gerald Fischbach currently serves as the scientific director overseeing the Simons Foundation Autism Research Initiative. Throughout Fischbach's career, much of his research has focused on the formation and function of the neuromuscular junction, which stemmed from his innovative use of cell culture to study synaptic mechanisms.
Huda Yahya Zoghbi, born Huda El-Hibri, is a Lebanese-born American geneticist, and a professor at the Departments of Molecular and Human Genetics, Neuroscience and Neurology at the Baylor College of Medicine. She is the director of the Jan and Dan Duncan Neurological Research Institute. She became the editor of the Annual Review of Neuroscience as of 2018.
Thomas Christian Südhof, ForMemRS, is a German-American biochemist known for his study of synaptic transmission. Currently, he is a professor in the school of medicine in the department of molecular and cellular physiology, and by courtesy in neurology, and in psychiatry and behavioral sciences at Stanford University.
The Simons Foundation Autism Research Initiative, or SFARI for short, is a research program established in 2005 by the Simons Foundation, which focuses on all aspects of autism research. Its director is Kelsey Martin. The organization has funded more than $200 million in autism research to 150 different investigators since 2007. The awards they give out include Bridge to Independence Awards, Pilot Awards, Research Awards, and Explorer Awards. One specific type of research they specialize in is mouse models of autism, which they are trying to make more available in cooperation with the Jackson Laboratory.
Helen Tager-Flusberg is an American psychology who is professor in the Department of Psychological and Brain Science at Boston University and the Departments of Anatomy and Neurobiology and Pediatrics at Boston University School of Medicine (BUSM). She is the Director of the Center for Autism Research Excellence at Boston University.
Mary Jane Rotheram-Borus is a licensed clinical psychologist and professor with the University of California, Los Angeles, Department of Psychiatry and Biobehavioral Sciences. Rotheram is the professor-in-residence in the Semel Institute for Neuroscience and Human Behavior. She is the Director of the Global Center for Children and Families at UCLA and the former director of the Center for HIV Identification, Prevention, and Treatment Services.
Daniel H. Geschwind is the Gordon and Virginia MacDonald Distinguished Professor of Human Genetics, Neurology and Psychiatry at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). He also directs the UCLA Neurogenetics Program and the UCLA Center for Autism Research and Treatment (CART), and holds the Gordon and Virginia MacDonald Distinguished Chair of Human Genetics there. Since March 1, 2016, he has served as the Senior Associate Dean and Associate Vice Chancellor for Precision Medicine at UCLA. His brother, Michael Geschwind, is also a professor of neurology, and behavioral neurology pioneer Norman Geschwind is his father's first cousin.
The Simons Foundation is an American private foundation established in 1994 by Marilyn and Jim Simons with offices in New York City. As one of the largest charitable organizations in the United States with assets of over $5 billion in 2022, the foundation's mission is to advance the frontiers of research in mathematics and the basic sciences. The foundation supports science by making grants to individual researchers and their projects.
Joann G. Elmore is a professor of medicine at the David Geffen School of Medicine, professor of Health Policy and Management at the UCLA Fielding School of Public Health Director of the UCLA National Clinician Scholars Program, the endowed chair in Health Care Delivery for The Rosalind and Arthur Gilbert Foundation, and a practicing physician . She publishes studies on diagnostic accuracy of cancer screening and medical tests in addition to AI/machine learning, using computer-aided tools to aid in the early detection process of high-risk cancers Previously, she held faculty and leadership positions at the University of Washington, Fred Hutchinson Research Center, Group Health Research Institute, Yale University and was the Associate Director and member of the National Advisory Committee for the Robert Wood Johnson Clinical Scholars Program at Yale and University of Washington. Elmore received her medical degree from the Stanford University School of Medicine, residency training in internal medicine at Yale-New Haven Hospital, with advanced epidemiology training from the Yale School of Epidemiology and Public Health and the RWJF Clinical Scholars Program. In addition, she was a RWJF generalist physician faculty scholar. Elmore is board certified in internal medicine and serves on many national and international committees. She is Editor in Chief for Adult Primary Care at Up-To-Date and enjoys seeing patients as a primary care internist and teaching clinical medicine to students and residents.
Catherine Lord is an American psychologist and researcher. She is widely recognized as one of the world’s leading experts in autism. She currently serves as a member of the International Advisory Board for the The Lancet Psychiatry, as co-chair of the Scientific Research Council of the Child Mind Institute, and as the George Tarjan Distinguished Professor of Psychiatry and Education at the Semel Institute for Neuroscience and Human Behavior at UCLA.
Linda M. Liau is an American neurosurgeon, neuroscientist, and the W. Eugene Stern Chair of the Department of Neurosurgery at the David Geffen School of Medicine at UCLA. Liau was elected to the Society of Neurological Surgeons in 2013 and the National Academy of Medicine in 2018. She has published over 230 research articles and a textbook, Brain Tumor Immunotherapy. She served as editor-in-chief of the Journal of Neuro-Oncology from 2007 to 2017.
Lindsay M. De Biase is an American neuroscientist and glial biologist as well as an assistant professor at the David Geffen School of Medicine at the University of California, Los Angeles. De Biase explores the diversity of microglia that exist within the basal ganglia circuitry to one day target regional or circuit-specific microglia in disease. De Biase's graduate work highlighted the existence and roles of neuron-OPC synapses in development and her postdoctoral work was critical in showing that microglia are not homogenous within the brain parenchyma.
Julie Ann Freischlag is an American vascular surgeon and current CEO of Atrium Health Wake Forest Baptist. She was the first female surgeon-in-chief of The Johns Hopkins Hospital and the first female chief of vascular surgery at the University of California, Los Angeles. In 2017, Freischlag was appointed Interim Dean of Wake Forest School of Medicine and CEO of the Wake Forest Baptist Medical Center. During the COVID-19 pandemic in North America, Freischlag was named chief academic officer of Atrium Health, Inc., and appointed the President-Elect of the American College of Surgeons.
Denise R. Aberle is an American radiologist and oncologist. As a professor of radiology in the David Geffen School of Medicine at UCLA and a professor of bioengineering in the UCLA Henry Samueli School of Engineering and Applied Science, Aberle was elected a member of the National Academy of Medicine and Fellow of the American Institute for Medical and Biological Engineering.
Anne Louise Coleman is an American ophthalmologist. She is currently the Chair of the Department of Ophthalmology and Director of the Stein Eye Institute at University of California, Los Angeles.
Beth Young Karlan is an American gynecologic oncologist. In 2008, she was named editor-in-chief of the medical journals Gynecologic Oncology and Gynecologic Oncology Reports. In 2012, Karlan was appointed by the White House to serve on the National Cancer Advisory Board, and in 2015, she was elected to the National Academy of Medicine.
A. Eugene Washington is an American physician, clinical investigator, and administrator. He served as the chancellor for health affairs at Duke University, as well as and the president and chief executive officer of the Duke University Health System, from 2015 to 2023. His research considers gynaecology, health disparities and public health policy. He was elected to the National Academy of Medicine in 1997 and the American Academy of Arts and Sciences in 2014.
